Mine Safety and Health Research Advisory Committee (MSHRAC), 62851-62852 [2022-22454]
Download as PDF
<![CDATA[
Federal Register / Vol. 87, No. 199 / Monday, October 17, 2022 / Notices
Records will be retrieved primarily by
an individual’s name or business email
address but may also be obtained by a
search using any search term or filter.
POLICIES AND PRACTICES FOR RETENTION AND
DISPOSAL OF RECORDS:
Records are retained and disposed of
in accordance with FHFA’s
Comprehensive Record Schedule, Item
6.2 (N1–543–11–1, approved on 01/11/
2013).
ADMINISTRATIVE, TECHNICAL, AND PHYSICAL
SAFEGUARDS:
Electronic records are protected by
controlled access procedures. Only
FHFA staff (and FHFA contractors
assisting such staff), whose official
duties require access, are allowed to
view, administer, and control these
records. The System Owner controls
access to this System and limits access
in accordance with the above.
RECORD ACCESS PROCEDURES:
See ‘‘Notification Procedures’’ Below.
CONTESTING RECORD PROCEDURES:
See ‘‘Notification Procedures’’ Below.
NOTIFICATION PROCEDURES:
Individuals seeking notification of
any records about themselves contained
in this System should address their
inquiry to the Privacy Act Officer, via
email to privacy@fhfa.gov or by mail to
the Federal Housing Finance Agency,
400 Seventh Street SW, Washington, DC
20219, or in accordance with the
procedures set forth in 12 CFR part
1204. Please note that all mail sent to
FHFA via the U.S. Postal Service is
routed through a national irradiation
facility, a process that may delay
delivery by approximately two weeks.
For any time-sensitive correspondence,
please plan accordingly.
EXEMPTIONS PROMULGATED FOR THE SYSTEM:
None.
HISTORY:
Clinton Jones,
General Counsel, Federal Housing Finance
Agency.
[FR Doc. 2022–22426 Filed 10–14–22; 8:45 am]
lotter on DSK11XQN23PROD with NOTICES1
BILLING CODE 8070–01–P
FEDERAL RETIREMENT THRIFT
INVESTMENT BOARD
Notice of Meeting of the Employee
Thrift Advisory Council
October 27, 2022 at 10 a.m.
VerDate Sep<11>2014
Meeting Agenda
1. Approval of the minutes of the May
24, 2022, Joint Board/ETAC meeting
2. Election of ETAC Chair
3. FY22 TSP Review
4. September 2022 Investment Program
Review—G, F, C, S, I, and L Funds
5. Converge Update
6. FY2023 FRTIB Budget
7. Participant Satisfaction Report
8. Legislative Update
9. New Business
Authority: 5 U.S.C. 552b(e)(1).
Dated: October 12, 2022.
Dharmesh Vashee,
General Counsel, Federal Retirement Thrift
Investment Board.
[FR Doc. 2022–22512 Filed 10–14–22; 8:45 am]
BILLING CODE P
17:35 Oct 14, 2022
Jkt 259001
To attend the virtual
meeting, please register at the website of
the National Institute for Occupational
Safety and Health (NIOSH) at
www.cdc.gov/niosh/mining/features/
2022-12mshrac.html or by telephone at
(412) 386–4541 at least 5 business days
in advance of the meeting. Registrants
will receive Zoom web conference
access information sent to their
provided email address upon successful
registration.
FOR FURTHER INFORMATION CONTACT:
George W. Luxbacher, P.E., Ph.D.,
Designated Federal Officer, MSHRAC,
NIOSH, CDC, 1600 Clifton Road NE,
Mailstop V24–4, Atlanta, Georgia
30329–4027; Telephone: (404) 498–
2808; Email: GLuxbacher@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: This Committee is charged
with providing advice to the Secretary,
Department of Health and Human
Services; the Director, CDC; and the
Director, NIOSH, on priorities in mine
safety and health research, including
grants and contracts for such research,
30 U.S.C. 812(b)(2), section 102(b)(2).
Matters to be Considered: The agenda
will include discussions on NIOSH
mining safety and health research
organizational structure, capabilities,
projects, and outcomes. The meeting
will also include an update from the
NIOSH Associate Director for Mining.
Agenda items are subject to change as
priorities dictate.
ADDRESSES:
Public Participation
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Mine Safety and Health Research
Advisory Committee (MSHRAC)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
of the Mine Safety and Health Research
Advisory Committee (MSHRAC). This is
a virtual meeting only. It is open to the
public, limited only by the number of
web conference lines (500 web
conference lines are available). If you
wish to attend virtually, please register
according to the instructions in the
addresses section below. Time will be
available for public comment.
DATES: The meeting will be held on
December 8, 2022, from 10:00 a.m. to
3:30 p.m., EST.
SUMMARY:
None.
DATES:
Telephonic. Dial-in (listen
only) information: Number: 1–202–599–
1426, Code: 970 258 547#; or via web:
https://teams.microsoft.com/l/meetupjoin/19%3ameeting_
MmE3OGUwNTYtNTFjOC0
0YzQyLTg3ZjQtNmExODUwZDhiNz
k5%40thread.v2/
0?context=%7b%22Tid%22%3a%
223f6323b7-e3fd-4f35-b43d-1a7afae59
10d%22%2c%22Oid%
22%3a%22533f2df2-5cef-4200-af1c6d760c60d9cf%22%7d
FOR FURTHER INFORMATION CONTACT:
Kimberly Weaver, Director, Office of
External Affairs, (202) 942–1640.
SUPPLEMENTARY INFORMATION:
ADDRESSES:
POLICIES AND PRACTICES FOR RETRIEVAL OF
RECORDS:
62851
PO 00000
Frm 00070
Fmt 4703
Sfmt 4703
Written Public Comment: The public
may submit written comments or
questions in advance of the meeting, to
the contact person above. Written
comments received in advance of the
meeting will be included in the official
record of the meeting, and questions
will be answered during the oral public
comment period open to public
participation.
Oral Public Comment: This meeting
will include time for members of the
public to make an oral comment. The
public comment session will be held on
December 8, 2022, at 3:00 p.m., EST, or
at the conclusion of planned
presentations, and conclude following
the final call for public comment.
Members of the public will be given 5
to 10 minutes each for comments.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
E:\FR\FM\17OCN1.SGM
17OCN1
62852
Federal Register / Vol. 87, No. 199 / Monday, October 17, 2022 / Notices
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2022–22454 Filed 10–14–22; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–23–1154]
lotter on DSK11XQN23PROD with NOTICES1
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled ‘‘Generic
Clearance for CDC/ATSDR Formative
Research and Tool Development’’ to the
Office of Management and Budget
(OMB) for review and approval. CDC
previously published a ‘‘Proposed Data
Collection Submitted for Public
Comment and Recommendations’’
notice on July 22, 2022 to obtain
comments from the public and affected
agencies. CDC did not receive comment
related to the previous notice. This
notice serves to allow an additional 30
days for public and affected agency
comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
VerDate Sep<11>2014
17:35 Oct 14, 2022
Jkt 259001
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
Generic Clearance for CDC/ATSDR
Formative Research and Tool
Development (OMB Control No. 0920–
1154, Exp. 1/31/2023)—Extension—
Office of Scientific Integrity (OSI),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The Centers for Disease Control and
Prevention (CDC) requests approval for
an Extension of a Generic Clearance for
CDC/ATSDR Formative Research and
Tool Development. This information
collection request is designed to allow
CDC to conduct formative research
information collection activities used to
inform many aspects of surveillance,
communications, health promotion, and
research project development at CDC.
Formative research is the basis for
developing effective strategies including
communication channels, for
influencing behavior change. It helps
researchers identify and understand the
characteristics—interests, behaviors and
needs—of target populations that
influence their decisions and actions.
Formative research is integral in
developing programs as well as
improving existing and ongoing
programs. Formative research looks at
the community in which a public health
intervention is being or will be
implemented and helps the project staff
understand the interests, attributes and
needs of different populations and
persons in that community. Formative
research occurs before a program is
designed and implemented, or while a
program is being conducted.
At CDC, formative research is
necessary for developing new programs
or adapting programs that deal with the
complexity of behaviors, social context,
cultural identities, and health care that
PO 00000
Frm 00071
Fmt 4703
Sfmt 4703
underlie the epidemiology of diseases
and conditions in the U.S. CDC
conducts formative research to develop
public-sensitive communication
messages and user-friendly tools prior to
developing or recommending
interventions, or care. Sometimes these
studies are entirely behavioral but most
often they are cycles of interviews and
focus groups designed to inform the
development of a product.
Products from these formative
research studies will be used for
prevention of disease. Findings from
these studies may also be presented as
evidence to disease-specific National
Advisory Committees, to support
revisions to recommended prevention
and intervention methods, as well as
new recommendations.
Much of CDC’s health communication
takes place within campaigns that have
fairly lengthy planning periods—
timeframes that accommodate the
standard federal process for approving
data collections. Short term qualitative
interviewing and cognitive research
techniques have previously proven
invaluable in the development of
scientifically valid and populationappropriate methods, interventions, and
instruments.
This request includes studies
investigating the utility and
acceptability of proposed sampling and
recruitment methods, intervention
contents and delivery, questionnaire
domains, individual questions, and
interactions with project staff or
electronic data collection equipment.
These activities will also provide
information about how respondents
answer questions and ways in which
question response bias and error can be
reduced.
This request also includes collection
of information from public health
programs to assess needs related to
initiation of a new program activity or
expansion or changes in scope or
implementation of existing program
activities to adapt them to current
needs. The information collected will be
used to advise programs and provide
capacity-building assistance tailored to
identify needs.
Overall, these development activities
are intended to provide information that
will increase the success of the
surveillance or research projects
through increasing response rates and
decreasing response error, thereby
decreasing future data collection burden
to the public. The studies that will be
covered under this request will include
one or more of the following
investigational modalities: (1) structured
and qualitative interviewing for
surveillance, research, interventions and
E:\FR\FM\17OCN1.SGM
17OCN1
]]>Agencies
[Federal Register Volume 87, Number 199 (Monday, October 17, 2022)]
[Notices]
[Pages 62851-62852]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-22454]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Mine Safety and Health Research Advisory Committee (MSHRAC)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC
announces the following meeting of the Mine Safety and Health Research
Advisory Committee (MSHRAC). This is a virtual meeting only. It is open
to the public, limited only by the number of web conference lines (500
web conference lines are available). If you wish to attend virtually,
please register according to the instructions in the addresses section
below. Time will be available for public comment.
DATES: The meeting will be held on December 8, 2022, from 10:00 a.m. to
3:30 p.m., EST.
ADDRESSES: To attend the virtual meeting, please register at the
website of the National Institute for Occupational Safety and Health
(NIOSH) at www.cdc.gov/niosh/mining/features/2022-12mshrac.html or by
telephone at (412) 386-4541 at least 5 business days in advance of the
meeting. Registrants will receive Zoom web conference access
information sent to their provided email address upon successful
registration.
FOR FURTHER INFORMATION CONTACT: George W. Luxbacher, P.E., Ph.D.,
Designated Federal Officer, MSHRAC, NIOSH, CDC, 1600 Clifton Road NE,
Mailstop V24-4, Atlanta, Georgia 30329-4027; Telephone: (404) 498-2808;
Email: [email protected].
SUPPLEMENTARY INFORMATION:
Purpose: This Committee is charged with providing advice to the
Secretary, Department of Health and Human Services; the Director, CDC;
and the Director, NIOSH, on priorities in mine safety and health
research, including grants and contracts for such research, 30 U.S.C.
812(b)(2), section 102(b)(2).
Matters to be Considered: The agenda will include discussions on
NIOSH mining safety and health research organizational structure,
capabilities, projects, and outcomes. The meeting will also include an
update from the NIOSH Associate Director for Mining. Agenda items are
subject to change as priorities dictate.
Public Participation
Written Public Comment: The public may submit written comments or
questions in advance of the meeting, to the contact person above.
Written comments received in advance of the meeting will be included in
the official record of the meeting, and questions will be answered
during the oral public comment period open to public participation.
Oral Public Comment: This meeting will include time for members of
the public to make an oral comment. The public comment session will be
held on December 8, 2022, at 3:00 p.m., EST, or at the conclusion of
planned presentations, and conclude following the final call for public
comment. Members of the public will be given 5 to 10 minutes each for
comments.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and
[[Page 62852]]
Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2022-22454 Filed 10-14-22; 8:45 am]
BILLING CODE 4163-18-P
